Inside The Two New Innovative Biotech ETFs From BioShares

The biotechnology corner of the broader health care industry has been one of the best performing U.S. sectors this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition (M&A) activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader…

Dow Over 18,000: Stocks Surge To Record-est Highs, Bond Bloodbath

Hhhmmm…. 1000 Points in 5 days… Dow 18,000… All-Time Record-er Highs… Best GDP In 11 Years… Shitty Durable Goods… Treasuries Crash… Crude Surges… Biotechs battered What Tepper is worried about… which fits with Yellen’s guidance for rate lift off… 5-Day run in stocks is best in over 3 years… Nasdaq underperformed today… and Trannies led (now…

PCE Price Index: Headline And Core Remain Well Below Target

The Personal Income and Outlays report for November was published this morning by the Bureau of Economic Analysis. The latest Headline PCE price index year-over-year (YoY) rate is 1.17%, down from 1.42% the previous month. The Core PCE index of 1.41% down from the previous month’s 1.53% YoY. As I’ve routinely observed, the general disinflationary trend in…

Gold Still In Bear Cycle?

GOLD- Well, not a merry Christmas for Gold buyers just yet. We have said in our TMTF forecast service to watch 1190 as KEY support and 1241 would also need to be taken out on a closing basis before we could confirm a new uptrend in Gold and the end to the 5 wave bear…

The Fracturing Bubble Down South: Brazil Is Another Victim Of Glo

Did Bloomberg recently acquire The Onion and fail to announce it? Well, you have to read its lead paragraph about Brazil’s latest outlook twice to be sure: Analysts reduced to 0.55 percent  their GDP estimate for 2015 from 0.69 percent the previous week, according to the Dec. 19 central bank survey of about 100 analysts published today. Apparently that’s a tradable data bite for some…